Purpose: Medication administration errors remain a persistent issue in the US healthcare system, impacting patient safety and leading to worsened outcomes, including increased mortality. Smart infusion pump interoperability with electronic health records (EHRs) has the potential to reduce intravenous (IV) medication administration errors. Smart Infusion pumps safely deliver IV medications using drug libraries that set standard dosing limits. Interoperability is their ability to wirelessly connect to EHRs to receive medications orders directly minimizing error-prone manual programming steps. However, despite being implemented over a decade ago, its real-world impact remains largely underexplored. Methods and Materials: A systematic literature review (SLR) of PubMed/Medline and Embase in November 2024 identified peer-reviewed studies assessing medication administration errors pre- and post- interoperability implementation in the inpatient hospital setting. The primary outcome measured error types directly impacted by interoperability. The secondary outcome assessed the cumulative reduction in medication administration errors. Results: Three studies met the inclusion criteria, spanning general community hospitals, pediatric facilities, and intensive care units (ICUs). For the primary outcome of assessing medication administration errors impactable by interoperability, interoperability implementation resulted in a 15.4% to 54.8% reduction in specific medication administration errors. For the secondary outcome of all medication administration errors, the cumulative reductions in medication administration errors post-implementation ranged from 21.2% to 90.5%, with variability influenced by baseline compliance, study setting, and patient populations. Conclusion: Smart infusion pump interoperability demonstrated consistent potential to enhance medication safety by addressing key error types and reducing cumulative errors in real-world settings. However, future research is needed to assess its impact on adverse drug events, clinician workflows, and patient outcomes. These findings underscore the importance of tailored implementation strategies to maximize interoperability’s effectiveness in improving patient safety. Plain Language Summary: Medication administration errors are a common issue in hospitals in the United States, with the potential to impact patient safety and lead to worsened outcomes. Smart infusion pump interoperability with electronic health records has the potential to reduce intravenous (IV) medication administration errors. Smart infusion pumps are infusion pumps that have drug libraries with standardized dosing. Interoperability is the technological advancement that wirelessly connects smart infusion pumps with EHRs, allowing medication orders to transfer directly instead of being entered manually. However, despite being implemented over a decade ago, its real-world impact remains largely underexplored in clinical practice. Therefore, we conducted a systematic literature review to identify studies assessing the impact of implementing smart infusion pump interoperability on medication administration errors in the inpatient hospital setting. Our review identified three studies assessing this impact. Two of the studies assessed our primary outcome of assessing medication administration errors impactable by interoperability and saw a post-implementation reduction ranging from 15.4% to 54.8%. All three of the studies assessed our secondary outcome of all medication administration errors and saw post-implementation reductions range from 21.2% to 90.5% post-implementation. Smart infusion pump interoperability demonstrated consistent potential to enhance medication safety by addressing key error types and reducing cumulative errors in real-world settings.
1 July 2025 in ClinicoEconomics and Outcomes Research
Purpose: To estimate the economic impact of implementing smart infusion pump interoperability for a hypothetical health system in the United States (US). Patients and Methods: An economic model was developed to assess the financial impact of implementing smart infusion pump interoperability with electronic health records (EHRs) for a health system. The model perspective was that of a moderately-large hypothetical US heath-system consisting of 6 hospitals, with 1,500 staffed beds and 50,000 discharges annually. The main outcomes of interest in this model were patient safety and outpatient intravenous (IV) administration charge capture. The impact of interoperability on patient safety was assessed by measuring the estimated reduction in preventable adverse drug events (pADEs). The impact on outpatient charge capture was assessed by estimating the reduction in lost charges due to the implementation of interoperability. All model parameters and inputs were derived and supported by peer-reviewed literature. Results: In the base-case analysis, the implementation of smart infusion pump interoperability resulted in an annual reduction of 56 pADEs, saving the health system $531,891 in associated pADE treatment costs. This equates to a total reduction of 281 pADEs over the 5-year time-horizon, with a cumulative cost savings of $2,659,457. Additionally, the implementation of interoperability recouped $2,419,673 in outpatient infusion administration charges annually, which is equivalent to $12,098,363 in recouped charges over five years. Conclusion: The implementation of smart infusion pump interoperability has the potential to enhance patient safety by reducing pADEs and improving outpatient administration charge capture. However, it is important to note that while the model is based on peer-reviewed model inputs, the model itself is theoretical in nature without real-world data validation and does not account for investment costs. Health systems should carefully evaluate the safety and economic implications of smart infusion pump interoperability when deciding whether to invest in this technology.
Drug dispensing in retail pharmacies typically involves several manual tasks that often lead to inefficiencies and errors. This is the first published quality improvement study in Latin America, specifically in Brazil, investigating the operational impacts of implementing a robotic dispensing system in a retail pharmacy. Through observational techniques, we measured the time required for the following pharmacy workflows before and after implementing the robotic dispensing system: customer service, receiving stock, stocking inventory, separation, invoicing, and packaging of online orders for delivery. Time savings were observed across all workflows within the pharmacy, notably in receiving stock and online order separation, which experienced 70% and 75% reductions in total time, respectively. Furthermore, customer service, stocking, invoicing, and packaging of online orders, also saw total time reductions from 36% to 53% after implementation of the robotic dispensing system. This study demonstrates an improvement in the pharmacy’s operational efficiency post-implementation of the robotic dispensing system. These findings highlight the potential for such automated systems to streamline pharmacy operations, improve staff time efficiency, and enhance service delivery.
30 August 2025 in Journal of the American Pharmacists Association
The Medicare Star Ratings program, administered by the Centers for Medicare & Medicaid Services, includes a list of quality measures aimed at evaluating the quality of care provided by Medicare health plans. These measures include three medication adherence measures (non-insulin antidiabetics, renin-angiotensin system antagonists (RASA), and statins), as well as a plan all-cause readmission (PACR) measure, among dozens of other measures. To examine the potential association between the three Medicare Star Rating medication adherence measures and the PACR measure. An analysis of the publicly available annual health plan Medicare Star Rating performance data was conducted for the Star Rating years of 2015-2024, except years 2021-2023 where the PACR measure was not assessed. The primary outcomes were odds ratios (OR) and 95% confidence intervals (CI) evaluating the likelihood of a health plan achieving ≥4-stars on the PACR measure if it also earned ≥4-stars or 5-stars on the adherence measure(s). Health plans that achieved ≥4-stars or 5-stars on the RASA measure had significantly higher odds of achieving ≥4-stars on the PACR measure (OR:1.53, 95% CI:1.30-1.81; OR:1.51, 95% CI:1.26-1.81; respectively), as did plans that achieved ≥4-stars or 5-stars on the statin adherence measure (OR:1.58, 95% CI:1.31-1.86; OR:1.94, 95% CI:1.55-2.43; respectively). There was no significant impact for the diabetes adherence measure (≥4-stars OR:1.10, 95% CI:0.93-1.30; 5-stars OR:1.09, 95% CI:0.89-1.33). The likelihood of achieving ≥4-stars on the PACR measure increased non-significantly with the number of adherence measures that achieved 5-stars (all 3 adherence measures OR:1.53, 95% CI:1.17-2.00; only 2 adherence measures OR:1.44, 95% CI:1.09-1.90; only 1 adherence measure OR:1.11, 95% CI:0.87-1.41). Health plans with higher performance on the Medicare Star Ratings adherence measures had significantly increased odds of high performance on the Medicare Star Ratings PACR measure, suggesting an association between effective medication management and reduced all-cause readmissions.
1 October 2015 in Biomedical Instrumentation & Technology
Article Citation: Tim Hoh, Idal Beer, and Pamela Krueger (2015) Ensuring Optimal Smart Pump Use Through Augmented User Interface. Biomedical Instrumentation & Technology: Infusion System Safety: Are We on the Right Path?, Vol. 49, No. s4, pp. 39-43. doi: http://dx.doi.org/10.2345/0899-8205-49.s4.39